Company intelligence / Profile preview

CytoSorbents

Princeton, New Jersey, United Statescytosorbents.com ↗

Ownership: Public · CTSO
Employees: ~150
Development stage: Commercial

Overview

CytoSorb®, the company’s flagship product based on proprietary polymer bead adsorption technology, has been used in over 270,000 treatments worldwide. It holds CE Mark approval for multiple indications across more than 70 countries. In the US it received FDA Emergency Use Authorization during COVID but does not yet have full FDA approval. The DrugSorb™ ATR system—targeting perioperative removal of antithrombotics—is under De Novo review with the FDA as of late 2024.

Therapeutic areas: GastroenterologyPulmonologyCardiovascularImmunologyOtherInfectious Diseases
Modalities: Device
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

CytoSorb

Commercial

Indications: Sepsis, Critical care, Cardiac surgery, Inflammatory conditions

Partnerships

Converge Biotech – strategic partnership to expand sepsis and critical care treatment with CytoSorb in IndiaDistribution partners globally for >70 countries

Financials

Market cap: $21.5M
Total revenue: $9.6M
Enterprise value: $43.4M

Beyond the preview

Go deeper on CytoSorbents.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CytoSorbents.

Explore the full profile